MS can occur at any age and presents itself more frequently in females than in males (69% vs. 31%). Current treatments for the condition reduce its relapse rate, but there is still an unmet need ...

Were you surprised by these results? What were the primary outcomes of the phase 2B study of tolebrutinib in relapsing multiple sclerosis? What was seen in the 3-year data? How do payers view the ...

The diagnosis of multiple sclerosis (MS) relies on a combination of clinical signs and symptoms, radiographic findings and laboratory results in the context of the revised 2017 McDonald diagnostic ...

Optic Neuritis: Clinical Features Optic neuritis refers to inflammation of the optic nerve. The term may be used broadly in reference to many causes of optic nerve inflammation including systemic ...

Multiple sclerosis (MS) is characterized by a broad array of symptoms. Despite this variability, most individuals with MS will exhibit a distinct set of symptoms during their initial clinical attack.

For people with multiple sclerosis (MS), a higher burden of comorbidity is associated with worse clinical outcomes ... Weekly Email Newsletter are free features that allow you to receive your ...

To help clinicians diagnose multiple sclerosis, an international team of ... and their association with clinical outcomes. Investigators in Australia concluded that choroid plexus enlargement ...

Lucid-MS is a first-in-class, non-immunomodulatory, neuroprotective compound for the treatment of multiple sclerosis (“MS ... disability. “Our clinical development team is thrilled ...

An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with their disorder, a new clinical trial suggests. The drug, tolebrutinib ...

But when this twitching is from multiple sclerosis (MS), this facial twitching may spread. It might go down your cheek to your mouth or jawline. And it happens more often. “It’s occurring mult ...

Researchers have found a potential new way to improve the treatment of multiple sclerosis (MS) using a novel combined therapy. The results build on two harmonized Phase I clinical trials ...

A generation ago, most people with multiple sclerosis could expect to rely on walkers and wheelchairs ... and team had applied for federal funding for the first clinical trial of the new medicine, ...